Novavax clears authorized hurdles, earnings name subsequent
Key Factors Novavax has resolved the dispute with the Vaccine Alliance, enabling the corporate to make substantial progress in attaining its mission. Novavax's protein vaccine Nuvaxovid inches nearer to Europe...